Journal of Acute Care

Register      Login

VOLUME 1 , ISSUE 1 ( January-April, 2022 ) > List of Articles

CASE REPORT

Challenges in Managing a Patient with Refractory Shock due to Telmisartan Overdose

Pooja R Murthy, Gopala K Ravi, KV Venkatesha Gupta, Poonam P Rai

Keywords : High-dose insulin—dextrose, Methylene blue, Refractory shock, Telmisartan

Citation Information : Murthy PR, Ravi GK, Gupta KV, Rai PP. Challenges in Managing a Patient with Refractory Shock due to Telmisartan Overdose. 2022; 1 (1):26-28.

DOI: 10.5005/jp-journals-10089-0001

License: CC BY-NC 4.0

Published Online: 12-07-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Angiotensin receptor blockers are commonly used to treat hypertension. However, the toxicity of this medication can be life-threatening and can cause severe hypotension and refractory shock. There are no case reports or published guidelines for its management. We hereby present a case of a young female with telmisartan overdose who was managed with multiple vasopressors and rescue therapies like methylene blue, high-dose glucose-insulin infusion, ascorbic acid, thiamine, steroids, and other agents. Early detection and intensive management of refractory shock are necessary to prevent mortality.


HTML PDF Share
  1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095–2128. DOI: 10.1016/S0140-6736(12)61728-0
  2. Anil R, Abhijit N. Suicide in India: a systematic review. Shanghai Arch Psychiatry 2014;26(2):69–80. DOI: 10.3969/j.issn.1002-0829.2014.02.003
  3. Prasa D, Hoffmann-Walbeck P, Barth S, et al. Angiotensin II antagonists - an assessment of their acute toxicity. Clin Toxicol (Phila) 2013;51(5):429–434. DOI: 10.3109/15563650.2013.800875
  4. Forrester MB. Valsartan ingestions among adults reported to Texas poison control centers, 2000 to 2005. J Med Toxicol 2007;3(4):157–163. DOI: 10.1007/BF03160932
  5. Bumier M. Angiotensin II type 1 receptor blockers. Circulation 2001;103:904–912. DOI: 10.1161/01.cir.103.6.904
  6. Manji F, Wierstra B, Posadas J. Severe undifferentiated vasoplegic shock refractory to vasoactive agents treated with methylene blue. Case Rep Crit Care 2017;2017:8747326. DOI: 10.1155/2017/8747326
  7. Kalkan S, Hocaoglu N, Oransay K, et al. Cardiovascular medication exposures and poisonings in Izmir, Turkey: a 14–year experience. Hum Exp Toxicol 2011;30(5):347–353. DOI: 10.1177/0960327110371256
  8. Moskowitz A, Andersen LW, Huang DT, et al. Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation. Crit Care 2018;22(1):283. DOI: 10.1186/s13054-018-2217-4
  9. Avcil M, Kapçı M, Yavaşoğlu I, et al. Simultaneous use of W lipid emulsion and plasma exchange therapies in multiple frug toxicity. Med Princ Pract 2016;25(6):577–579. DOI: 10.1159/000449250
  10. Sundar SS, Madhusoodhanan NN, Siroraj AP, et al. Extracorporeal membrane oxygenation for cardiotoxic drug overdose- a lifesaving intervention. J cardiac crit care TSS 2017;1(2): 105–107. DOI: 10.1055/s-0038-1626678
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.